1999
DOI: 10.1016/s0960-9822(99)80364-9
|View full text |Cite
|
Sign up to set email alerts
|

Ribosomal S6 kinase 1 (RSK1) activation requires signals dependent on and independent of the MAP kinase ERK

Abstract: RSK1 is phosphorylated by PDK1 in the amino-terminal kinase-activation loop, and by ERK in the carboxy-terminal kinase-activation loop. Activation of phosphotransferase activity of full-length RSK1 in vivo requires both PDK1 and ERK. RSK1 activation is therefore regulated by both the mitogen-stimulated ERK/MAP kinase pathway and a PDK1-dependent pathway.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
130
0

Year Published

2001
2001
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 135 publications
(132 citation statements)
references
References 43 publications
1
130
0
Order By: Relevance
“…ERK is thought to initiate the sequential phosphorylation of multiple S6KII residues by binding to a specific docking domain at the terminus of the protein, resulting in phosphorylation of residue T732 (and perhaps also S498) (T573 and S363 in RSK, respectively) and subsequent activation of the C-terminal kinase (22)(23)(24). The C-terminal kinase autophosphorylates S515 (RSK S380), creating a binding site for PDK1, which then docks and phosphorylates S6KII S357 (RSK S221), activating the N-terminal kinase domain and enabling the phosphorylation of S6KII target substrates (14,(25)(26)(27).…”
Section: Transgenic Expression Of Mutant Proteins For the Assay Of S6mentioning
confidence: 99%
“…ERK is thought to initiate the sequential phosphorylation of multiple S6KII residues by binding to a specific docking domain at the terminus of the protein, resulting in phosphorylation of residue T732 (and perhaps also S498) (T573 and S363 in RSK, respectively) and subsequent activation of the C-terminal kinase (22)(23)(24). The C-terminal kinase autophosphorylates S515 (RSK S380), creating a binding site for PDK1, which then docks and phosphorylates S6KII S357 (RSK S221), activating the N-terminal kinase domain and enabling the phosphorylation of S6KII target substrates (14,(25)(26)(27).…”
Section: Transgenic Expression Of Mutant Proteins For the Assay Of S6mentioning
confidence: 99%
“…Full catalytic activity of Rsks requires activation by both extracellular signal-regulated kinase (ERK) 21,22 and PDK1 (3-phosphoinositide-dependent protein kinase 1). 23,24 Rsk family kinases have multiple cellular functions. They are involved in the phosphorylation of histone H3 and remodeling of chromatin in response to epidermal growth factor (EGF) 25 and can regulate gene expression by phosphorylating transcription factors, including c-Fos, 26,27 cAMP-response element-binding protein (CREB), [28][29][30] CREB-binding protein, 31,32 estrogen receptor, 33 ATF4,34 NFATc4, 35 and NF-B/I B␣.…”
Section: Introductionmentioning
confidence: 99%
“…The activated CTK then autophosphorylates the RSKs to permit docking of PDK1 that then phosphorylates a Ser residue (Ser-221 in rat RSK1) in the activation loop of the NTK (11). The fully active RSKs, via their NTK, then phosphorylate their respective substrates (12). The fully active RSK1 and RSK2 are also translocated to the nucleus where they phosphorylate several transcription factors to mediate their biological actions (13).…”
mentioning
confidence: 99%